Megasoft (NSE:MEGASOFT) Change In Receivables : ₹0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Megasoft Change In Receivables?

Megasoft's change in receivables for the quarter that ended in Mar. 2024 was ₹0.00 Mil. It means Megasoft's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Megasoft's change in receivables for the fiscal year that ended in Mar. 2024 was ₹141.54 Mil. It means Megasoft's Accounts Receivable declined by ₹141.54 Mil from Mar. 2023 to Mar. 2024 .

Megasoft's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Megasoft's liquidation value for the three months ended in Mar. 2024 was ₹-1,668.23 Mil.

Megasoft Change In Receivables Historical Data

The historical data trend for Megasoft's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Megasoft Change In Receivables Chart

Megasoft Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

-42.99

261.82

117.41

175.14

141.54

Megasoft Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Megasoft Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

Megasoft (NSE:MEGASOFT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Megasoft's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, Megasoft's accounts receivable are only considered to be worth 75% of book value:

Megasoft's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	184.918	-	1853.144	+	0.75 * 0	+	0.5 * 0
=	-1,668.23

Megasoft Change In Receivables Related Terms

Thank you for viewing the detailed overview of Megasoft's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Megasoft (NSE:MEGASOFT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Megasoft Ltd (NSE:MEGASOFT) » Definitions » Change In Receivables

Traded in Other Exchanges

532408:India

Address

Image Gardens Road, 8th Floor, Unit No. 801B, Plot No. 1, 28 & 29, 98/4/1 to 13, Jain Sadguru Image’s Capital Park, Madhapur, Hyderabad, TG, IND, 500081

Website

http://www.megasoft.com

Megasoft Ltd is focused on Pharma, Aerospace and Defense Electronics areas and is in the process of acquiring a few companies and intends to provide centralized corporate, technology, finance, and leadership/management support services to such subsidiaries/associate companies. The company has invested in Extrovis AG, a company engaged in Pharmaceutical R&D and in the business of development, production, distribution and sale of chemicals and pharmaceuticals of all kinds has a wide range of activities aimed at bringing safe, effective, and high-quality drugs to the market.

Megasoft (NSE:MEGASOFT) Headlines

No Headlines